ST
AMPH icon

Sageworth Trust’s Amphastar Pharmaceuticals AMPH Stock Holding History

Sageworth Trust’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-48
Closed -$1K – 376
2021
Q4 		$1K Sell
48
-162
-77% -$3.31K ﹤0.01% 662
2021
Q3 		$4K Hold
210
– – ﹤0.01% 709
2021
Q2 		$4K Buy
+210
New +$3.96K ﹤0.01% 746

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Sageworth Trust's AMPH Position: Q1 2022 in Review

Sageworth Trust sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2022, closing a stake of 48 shares — an estimated $1K sold.

Sageworth Trust first reported a position in AMPH in Q2 2021 and held it in 3 quarters. The position peaked at $4K in Q3 2021. 203 funds tracked by Wall St. Rank hold AMPH as of Q1 2022.

  • Sageworth Trust reported no remaining Amphastar Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Sageworth Trust sold 48 Amphastar Pharmaceuticals shares in Q1 2022, an estimated $1K.
  • Sageworth Trust first reported a position in Amphastar Pharmaceuticals in Q2 2021 and held it in 3 quarters.
  • Sageworth Trust's Amphastar Pharmaceuticals position peaked at $4K in Q3 2021.
  • 203 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2022.

Based on Sageworth Trust's 13F filing for Q1 2022, filed 6 May 2022.